ASA.F ASAHI KASEI CORP. ADR/2
- Market cap
- EUR 11.9B
- P/E
- 11.0x
- P/B
- 0.99x
- ROE
- 10.2%
- Dividend yield
- 2.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is ASA.F undervalued?
Graham numberASA.F trades 30.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ASAHI KASEI CORP. ADR/2 fundamental analysis
No fundamental analysis for ASAHI KASEI CORP. ADR/2 yet.
ASAHI KASEI CORP. ADR/2 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ASAHI KASEI CORP. ADR/2
Asahi Kasei Corporation engages in material, homes, and healthcare businesses in Japan, the United States, China, and internationally. The company offers Pimel, a photosensitive PI material applied for semiconductor applications, such as buffer coating, passivation layers, and dielectric layers; Sunfort, a dry film photoresist; Novacure, a latent curing agent for epoxy resin; glass fabric for printed circuit boards; plastic optical fiber; sensors and devices; artificial sued…
Full company profileASAHI KASEI CORP. ADR/2 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ASAHI KASEI CORP. ADR/2 annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 2.46T | 2.73T | 2.78T | 3.04T | 3.07T | 3.30T |
| Gross Profit | 770B | 774B | 816B | 958B | 1.01T | 1.16T |
| Operating Income | 203B | 128B | 141B | 212B | 231B | 325B |
| EBITDA | - | 121B | 218B | 390B | 423B | 571B |
| Net Income | 162B | -91.9B | 43.8B | 135B | 159B | 215B |
| EPS | 117 | -66 | 32 | 99 | 117 | 160 |
| Balance Sheet | ||||||
| Total Assets | 3.35T | 3.45T | 3.66T | 4.02T | 4.14T | 4.46T |
| Total Liabilities | 1.63T | 1.76T | 1.81T | 2.10T | 1.97T | 2.26T |
| Shareholders' Equity | 1.69T | 1.66T | 1.81T | 1.86T | 2.09T | 2.12T |
| Cash & Short-term Investments | 245B | 251B | 338B | 393B | 377B | 387B |
| Cash Flow | ||||||
| Operating Cash Flow | 183B | 90.8B | 295B | 301B | 303B | 57.0B |
| Capital Expenditure | 170B | 172B | 172B | 218B | 211B | 246B |
| Free Cash Flow | 13.6B | -81.4B | 123B | 83.6B | 92.1B | -189B |
| Ratios | ||||||
| ROE | 9.6% | -5.5% | 2.4% | 7.3% | 7.6% | 10.2% |
| ROA | 4.8% | -2.7% | 1.2% | 3.4% | 3.8% | 4.8% |
| Net Profit Margin | 6.6% | -3.4% | 1.6% | 4.4% | 5.2% | 6.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ASAHI KASEI CORP. ADR/2 dividends
- Dividend yield
- 2.69%
- Forward dividend
- 0.46 EUR
- Payout ratio
- 34.2%
- Ex-dividend date
- Mar 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 54.4B | 40 | 34.2% |
| 2025 | JPY 50.0B | 37 | 37.0% |
| 2024 | JPY 50.0B | 36 | 114.1% |
| 2023 | JPY 48.6B | 35 | - |
| 2022 | JPY 47.2B | 34 | 29.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ASAHI KASEI CORP. ADR/2
- Insiders 0.00%
- Institutions 0.00%
- Public & others 100.00%
- Shares outstanding 667M
- Free float 648M
ASAHI KASEI CORP. ADR/2 company profile
- Company name
- ASAHI KASEI CORP. ADR/2
- Ticker
- ASA.F
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Chemicals
- Employees
- 47,895
- Fiscal year end
- March
- Address
- Hibiya Mitsui Tower, Chiyoda, Japan, 100-0006
- Phone
- 81 3 6699 3030
- Website
- asahi-kasei.com
About ASAHI KASEI CORP. ADR/2
Asahi Kasei Corporation engages in material, homes, and healthcare businesses in Japan, the United States, China, and internationally. The company offers Pimel, a photosensitive PI material applied for semiconductor applications, such as buffer coating, passivation layers, and dielectric layers; Sunfort, a dry film photoresist; Novacure, a latent curing agent for epoxy resin; glass fabric for printed circuit boards; plastic optical fiber; sensors and devices; artificial suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; alkaline water electrolyzer for producing hydrogen from renewable energy Aqualyzer; Hipore, a microporous polyolefin sheet which prevents the anode and cathode; Celgard, a lithium-ion battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, Bemliese, NanoAct, and ROICA names. It also provides cling film, bags, and containers under the Saran Wrap, Ziploc, and Cookper names; packaging products under the Suntec, Barrialon, PVDC latex, and Saran fiber names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company offers prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; virus removal filters; wearable defibrillators, temperature management systems, pre-hospital, and hospital data management systems; overseas homes, unit homes and apartment buildings, and real estate-related operations; autoclaved aerated concretes, foundation systems, thermal insulations, and structural systems and component products; polymers, monomers, foamed products, and cleaners; and synthetic rubber, elastomers, and intermediates and inorganic chemicals. Asahi Kasei Corporation was founded in 1922 and is headquartered in Chiyoda, Japan.
ASAHI KASEI CORP. ADR/2 management
10- Mr. Koshiro KudoPresident, Presidential Executive Officer for Material Business Sector & Representative Director · born 1959
- Mr. Toshiyasu HorieCFO, Executive Officer of Strategy, Accounting, Finance & IR, Primary EO and Representative Director · born 1962
- Nobuhiro YamaguchiLead Ex. Officer and Ex. Officer for General Affairs, Legal, Corporate Comm, Risk Mgt & Compliance
- Satoshi NishikawaSenior Executive Officer & Executive Officer for HR
- Mr. Richard A. PackerVice-Presidential Executive Officer & Executive Officer?Corporate Initiatives · born 1958
- Hideyuki YamagishiPrimary Executive Officer
- Mr. Jonathan A. RennertSenior Executive Officer · born 1964
- Mr. Hideki TsutsumiSenior Executive Officer and Executive Officer for Procurement & Logistics · born 1961
- Mr. Fumitoshi KawabataVice-Presidential Executive Officer & EO for Homes Business Sector · born 1958
- Yukifumi KuwabaLead Executive Officer